Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenomic landscape of adult Philadelphia chromosome-positive acute lymphoblastic leukemia in Malaysia.

Cancer genetics·2026
Same author

Local-friction governs water mobility in hydrogels acting as extracellular mimics.

Physical chemistry chemical physics : PCCP·2026
Same author

A Rare Case of <i>De Novo</i> α-Globin Cluster Duplication, ααα<sup>102</sup> (NC_000016.10: G.79903_181947dup) in a β-Thalassemia IVS 1-1 (G>T) (<i>HBB</i>: C.92 + 1G>T) Carrier with Thalassemia Intermedia Phenotype.

Hemoglobin·2026
Same author

Single Nucleotide Polymorphism Microarray Analysis Unveils Copy-Number Abnormalities and Genetic Heterogeneity in Malaysian Childhood B-Cell Precursor Acute Lymphoblastic Leukemia.

Molecular genetics & genomic medicine·2026
Same author

Empowering molecular complexity <i>via</i> biocatalysis: emerging blueprints in the total synthesis of medicinally relevant natural products.

RSC medicinal chemistry·2026
Same author

Epidemiological Profile of Haemoglobinopathies in Different Districts of West Bengal: A Retrospective Study.

Nigerian medical journal : journal of the Nigeria Medical Association·2025

Related Experiment Video

Updated: May 21, 2026

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

Cell therapy in critical limb ischemia: current developments and future progress.

Murali Krishna Mamidi1, Rajarshi Pal, Sovan Dey

  • 1Stempeutics Research Malaysia Sdn Bhd, Kuala Lumpur, Malaysia.

Cytotherapy
|June 27, 2012
PubMed
Summary
This summary is machine-generated.

Cell-based therapy shows promise for critical limb ischemia (CLI) treatment, offering an alternative for patients unsuitable for traditional revascularization. Further research is needed to optimize stem cell application for improved limb salvage and patient outcomes.

More Related Videos

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Related Experiment Videos

Last Updated: May 21, 2026

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Area of Science:

  • Regenerative Medicine
  • Vascular Surgery

Background:

  • Critical limb ischemia (CLI) presents with severe pain, ulcers, and tissue loss, leading to high amputation rates and mortality.
  • Current revascularization options are unsuitable for up to 30% of CLI patients due to medical risks or anatomical limitations.
  • Novel therapeutic strategies are imperative for limb salvage and improved quality of life in CLI patients.

Purpose of the Study:

  • To review current advancements in cell-based therapy for critical limb ischemia (CLI).
  • To highlight stem cell therapy as a promising alternative revascularization strategy.
  • To identify challenges and future research directions for clinical translation.

Main Methods:

  • Review of recent scientific literature on cell-based therapies for CLI.
  • Analysis of preliminary clinical data on stem cell safety, feasibility, and efficacy.
  • Identification of key areas for future research and development.

Main Results:

  • Cell-based therapies, particularly stem cell treatments, demonstrate safety, feasibility, and efficacy in preliminary CLI studies.
  • Numerous ongoing studies aim to further validate these findings.
  • Significant challenges remain in understanding and controlling transplanted cell behavior in vivo.

Conclusions:

  • Cell-based therapy represents a promising alternative for CLI patients ineligible for conventional revascularization.
  • Further research is essential to address hurdles in cell survival, migration, and differentiation for successful clinical application.
  • Future studies should focus on optimizing cell isolation, dosage, type, administration, and supportive factors.